Abstract
Epidemiological studies have identified numerous existing medications that appear to be associated with a reduced incidence or progression of Alzheimer's disease. The literature surrounding these studies is confusing because of conflicting data. Retrospective epidemiological studies of both statins and nonsteroidal anti-inflammatory drugs (NSAIDs) show an association between medication use and a reduced incidence or progression of AD (Breitner et al., 1994; Jick, Zornberg, Jick, Seshadri, & Drachman, 2000; Wolozin, Kellman, Ruosseau, Celesia, & Siegel, 2000).
Cite
CITATION STYLE
Wolozin, B. (2007). Interpreting clinical studies of putative therapeutics for Alzheimer’s disease: The case of statins and NSAIDs. In Pharmacological Mechanisms in Alzheimer’s Therapeutics (pp. 296–308). Springer New York. https://doi.org/10.1007/978-0-387-71522-3_18
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
